Rapid tests have become indispensable diagnostic tools in modern general practices. Streptococcal-A, Influenza, and COVID-19 rapid tests enable quick diagnosis within minutes and form the basis for targeted, evidence-based therapy decisions. In times of increasing antibiotic resistance and the need for precise differential diagnosis in respiratory infections, Point-of-Care Tests (POCT) are of enormous clinical relevance. This overview shows which tests have proven themselves in practice, what to pay attention to when using them and how to interpret the results correctly.
Table of Contents
Basics of Rapid Test Diagnostics
Point-of-Care Tests (POCT) are diagnostic tests that can be carried out directly on the patient or in their immediate vicinity without the need for extensive laboratory infrastructure. In general practices, immunological rapid tests, which are based on the detection of specific antigens or antibodies, play a central role.
Function Principle of Immunological Rapid Tests
Most rapid tests used in practice utilize the Lateral-Flow-Technology. Here, the antigen to be detected binds to labeled antibodies and is transported along a test membrane. Additional antibodies are located at defined positions and produce visible lines in the case of a positive test. This method is robust, requires no power supply, and delivers results within 5-15 minutes.
Streptococcal-A Rapid Tests
Streptococcus pyogenes (Group A Streptococci, GAS) is the most common bacterial cause of acute pharyngitis. Correct diagnosis is crucial to avoid unnecessary antibiotic administration and at the same time prevent complications such as rheumatic fever or glomerulonephritis.
Clinical Indication
A Strep-A test is indicated for patients with acute pharyngitis and signs of bacterial origin. The Centor Score or the modified McIsaac Score help in estimating pre-test probability:
- Fever over 38°C (1 point)
- Absence of cough (1 point)
- Swollen, tender cervical lymph nodes (1 point)
- Tonsillar exudates or swelling (1 point)
- Age 3-14 years (+1 point), 15-44 years (0 points), over 45 years (-1 point)
With a score of 2-3 points, a Strep-A test makes sense. With 4 points, empirical antibiotic therapy can also be considered, while 0-1 points suggests a viral cause is likely.
Test Procedure
Correct sample collection is crucial for test quality. A sterile throat swab should intensively contact both tonsils and the posterior pharynx, avoiding the tongue or buccal mucosa. The swab is placed into the supplied extraction solution and processed according to the manufacturer's instructions.
Interpretation and Consequences
A positive Strep-A test justifies antibiotic therapy with Penicillin V (phenoxymethylpenicillin) for 10 days or alternatively an oral cephalosporin for 5-7 days in case of penicillin allergy. The antibiotic treatment shortens symptom duration by about 1-2 days and significantly reduces the risk of complications.
Influenza Rapid Tests
Influenza types A and B cause annual seasonal epidemics with significant morbidity and mortality, especially among risk groups. Rapid diagnosis enables early antiviral therapy and targeted isolation measures.
Test Indication and Time Window
Influenza rapid tests are particularly valuable during influenza season (typically December to March in Austria) in patients with:
- Acute onset of fever over 38.5°C
- Myalgia and marked malaise
- Respiratory symptoms (cough, rhinitis)
- Belonging to risk groups (over 65 years, chronic diseases, pregnancy)
Testing is most informative within the first 72 hours after symptom onset, as the viral load is highest at this time.
Sample Collection and Test Procedure
For influenza rapid tests, nasopharyngeal or nasal swabs are suitable. The swab should be passed through both nostrils with rotary movements and advanced to the nasopharynx. Modern influenza tests differentiate between influenza A and B and deliver results in 10-15 minutes.
Sensitivity and Specificity
The sensitivity of conventional influenza rapid tests is 50-70%, and specificity about 90-95%. Newer digital immunoassay-based tests achieve sensitivities up to 80%. The moderate sensitivity means that a negative test result does not safely exclude influenza, while a positive result is very reliable when prevalence is high.
Therapeutic Consequences
A positive influenza test in risk patients justifies the use of Oseltamivir (75 mg twice daily for 5 days) or Zanamivir (inhalation). Antiviral therapy shortens disease duration by about 1 day and significantly reduces complications such as pneumonia. In addition, diagnosis allows a reduction of unnecessary antibiotic prescriptions.
COVID-19 Rapid Tests
SARS-CoV-2 antigen tests have established themselves as practical Point-of-Care solutions for quickly identifying COVID-19 infections. They supplement the more sensitive but time-consuming PCR tests and allow for quick clinical decisions.
Test Principle and Scope of Application
COVID-19 antigen tests detect viral nucleocapsid or spike proteins. They are particularly reliable at high viral loads (typically in the first 5-7 days after symptom onset). The main indications include:
- Symptomatic patients suspected of COVID-19
- Contacts of confirmed cases
- Preoperative screenings or prior to invasive procedures
- Outbreak management in community facilities
Sample Collection and Test Procedure
The standard method is the nasopharyngeal swab, although nasal swabs (both nostrils, 2 cm deep, 15 seconds circular motion) achieve acceptable sensitivities. The swab is placed into the extraction solution, and a few drops are applied to the test cassette. The result is available after 15-30 minutes.
Performance Parameters
The sensitivity of COVID-19 antigen tests varies depending on viral load and timing: in symptomatic patients with high viral load (Ct value below 25 in PCR), it is 85-95%, with lower viral loads dropping to 50-70%. The specificity is consistently above 97%. This means that positive results are very reliable, whereas negative results with justified clinical suspicion should be confirmed by PCR.
Clinical Consequences
A positive COVID-19 antigen test result requires isolation measures according to current health authority recommendations. For risk patients, the indication for antiviral therapy (e.g., Nirmatrelvir/Ritonavir) should be considered if therapy begins within 5 days of symptom onset. A negative result with high clinical suspicion should be verified by PCR.
Comparison Table of Test Methods
| Parameter | Strep-A Test | Influenza Test | COVID-19 Antigen Test |
|---|---|---|---|
| Sample Material | Throat swab (tonsils, pharynx) | Nasopharyngeal or nasal swab | Nasopharyngeal or nasal swab |
| Test Duration | 5-10 minutes | 10-15 minutes | 15-30 minutes |
| Sensitivity | 70-90% | 50-80% | 85-95% (high viral load), 50-70% (low viral load) |
| Specificity | 95-99% | 90-95% | 97-99% |
| Optimal Time Window | Acute phase of pharyngitis | First 72 hours after symptom onset | First 5-7 days after symptom onset |
| Main Indication | Acute pharyngitis, Centor-Score 2-3 | Influenza-typical symptoms in risk patients | COVID-19 suspicion, contact person testing |
| Therapeutic Consequence | Antibiotic therapy (Penicillin V) | Antiviral therapy (Oseltamivir) in risk patients | Isolation, possibly antiviral therapy in risk patients |
| Confirmation of Negative Result | Culture with high clinical probability | Clinical decision, if necessary PCR | PCR with justified suspicion |
Practical Tips for Optimal Use
The quality of sample collection significantly determines test accuracy. For throat swabs: patients should not eat, drink or brush their teeth just before. Guide the swab with sufficient pressure over both tonsils and the posterior pharynx. In nasal swabs: introduce the swab at least 2 cm deep and rotate against the nasal septum with circular movements for 15 seconds. Test both nostrils successively with the same swab.
Rapid tests should be stored at room temperature (15-30°C). Tests taken from the refrigerator must be brought to room temperature before use (at least 30 minutes). The test cassette should only be removed from packaging immediately before use to avoid moisture exposure. Strictly observe expiration dates – expired tests may result in false-negative results.
The reading must occur within the time frame specified by the manufacturer (typically 15-30 minutes). Tests read too early may be falsely negative, tests read too late can show false-positive lines due to evaporation effects. Document the test result with a time indication. A faint test line should be considered positive if it appears within the reading window.
The interpretation of a test result greatly depends on clinical probability. At high prevalence (e.g., influenza during flu season, Strep-A in typical pharyngitis), the positive predictive value rises. At low prevalence, the risk of false positive findings increases. Use clinical scores (Centor, FeverPAIN) to estimate pre-test probability and consider further diagnostics in case of discrepancies between the clinical picture and test result.
Quality Assurance and Legal Aspects
Quality Assurance Measures
According to the Austrian Medical Act and guidelines of the Austrian Medical Association, Point-of-Care Tests in medical practices are subject to quality assurance obligations:
- Internal Quality Control: Performing control tests with every new test batch and at regular intervals (at least monthly) with positive and negative controls
- External Quality Control: Participation in ring trials, if available
- Documentation: Maintaining a POCT logbook with test batch, expiration date, quality control results, and executing person
- Training: Regular training of medical staff in correct test procedure and interpretation
Legal Framework
Rapid tests must have a CE marking as an In vitro diagnostic device (IVD). Since May 2022, the new EU Regulation on In Vitro Diagnostics (IVDR) imposes increased requirements for performance evaluation and clinical evidence. Practice operators should only use tests that can demonstrate IVDR compliance.
Economic Aspects
The costs for rapid tests vary depending on the manufacturer and purchase quantity: Strep-A tests cost about 2-4 euros per test, influenza tests 8-15 euros, COVID-19 antigen tests 2-5 euros. In Austria, certain rapid tests can be billed within the framework of contractual arrangements. An economic analysis must consider the diagnostic benefit, reduction of unnecessary antibiotic prescriptions, and patient satisfaction.
Conclusion and Recommendations for Action
Rapid tests for streptococci A, influenza, and COVID-19 are valuable diagnostic tools in modern general practice. They allow rapid, evidence-based therapy decisions and contribute to reducing unnecessary antibiotic prescriptions. Correct application, proper interpretation taking into account clinical probability, and considering limitations are crucial for optimal use.
Specific Recommendations for Practice:
- Use clinical scores (Centor, McIsaac) to select patients for Strep-A testing
- Perform influenza tests preferably within the first 72 hours after symptom onset
- Consider the timing and symptomatology in COVID-19 tests - PCR confirmation if uncertain
- Establish structured quality management for POCT in your practice
- Regularly train your team in correct test execution and sample collection
- Systematically document test results and observe reporting obligations
- Communicate the limitations of rapid tests transparently to patients
When applied correctly, rapid tests significantly improve the quality of patient care and make an important contribution to rational diagnostics and therapy in primary care.
0 Comments